Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer Science|October 27, 2016
Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses effectively suppress growth of malignant pleural mesotheliomaAkiko Harada, Junji Uchino, Taishi Harada, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 30, 2013
Nicotine induces resistance to epidermal growth factor receptor tyrosine kinase inhibitor by α1 nicotinic acetylcholine receptor-mediated activation in PC9 cellsShuo Wang, Koichi Takayama, Kentaro Tanaka, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|August 10, 2011
Inhalative administration of insulin using a new bubble jet atomization deviceJunko Hisasue, Satoru Fukuyama, Noriaki Nakagaki, et al.
Anticancer Research|February 4, 2019
Identification of Genomic Alterations Acquired During Treatment With EGFR-TKIs in Non-small Cell Lung CancerNaoki Kubo, Taishi Harada, Yoshimasa Shiraishi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 16, 2013
A new cancer cell detection method using an infectivity-enhanced adenoviral vectorJunji Uchino, Koichi Takayama, Noriaki Nakagaki, et al.
Oncotarget|October 6, 2017
Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor-naïve patients with non-small cell lung cancer harboring EGFR mutationsKentaro Tanaka, Kaname Nosaki, Kohei Otsubo, et al.
The Oncologist|April 27, 2019
Genetic Profiling of Non-Small Cell Lung Cancer at Development of Resistance to First- or Second-Generation EGFR-TKIs by CAPP-Seq Analysis of Circulating Tumor DNAKohei Otsubo, Kazuko Sakai, Masafumi Takeshita, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201)Minoru Fukuda, Takeshi Kitazaki, Daiki Ogawara, et al.
Cancer|September 11, 2019
Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor-tyrosine kinase inhibitorsEiji Iwama, Kazuko Sakai, Noriko Hidaka, et al.
Scientific Reports|May 30, 2025
Mortality and exacerbation risk according to GOLD and STAR severity stages of COPD: a 5-year multicenter prospective cohort studyHiroaki Ogata, Kazuya Tsubouchi, Tomotsugu Takano, et al.
Pageof 2